HeartCore is a manufacturing company.
DiscGenics, Inc. is a clinical-stage biotechnology company focused on developing cell-based regenerative therapies specifically for degenerative diseases of the spine, particularly those affecting the intervertebral disc. The company utilizes allogeneic therapeutic progenitor cells derived from intervertebral disc tissue to create an injectable, homologous cell therapy. This innovative approach aims to provide a non-surgical alternative that alleviates pain and restores function in patients suffering from conditions related to the intervertebral disc. DiscGenics employs its tissue engineering platform technology to offer a promising solution to the limitations of current therapeutic options. Founded in 2007, the company is headquartered in Salt Lake City, Utah, and actively publishes scientific research to support its developments.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.